Identification of potent CNS-penetrant thiazolidinones as novel CGRP receptor antagonists
Pramod Joshi1, Corey Anderson1, Hayley Binch1
1Vertex Pharmaceuticals Inc., Department of Chemistry and Drug Innovation, 11010 Torreyana Road, San Diego, CA 92121, United States.
Abstract:
Calcitonin gene-related peptide (CGRP) has been implicated in acute migraine pathogenesis. In an effort to identify novel CGRP receptor antagonists for the treatment of migraine, we have discovered thiazolidinone 49, a potent (Ki=30 pM, IC50=1 nM), orally bioavailable, CNS-penetrant CGRP antagonist with good pharmacokinetic properties.
More Related Videos
Related Concept Videos
Antipsychotic Drugs: Typical and Atypical Agents
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists


